Oral Cancer Treatment Market

Market Overview:

The global oral cancer treatment market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 5.50% during 2023-2028. The thriving healthcare industry, increasing prevalence of oral cancer, and the rising awareness among the masses about the benefits of oral cancer treatments represent some of the key factors driving the market.

Oral cancer, also known as mouth cancer, refers to cancer that develops in lips, gums, tongue, inner lining of the cheeks, and the roof and floor of the mouth. It shows various symptoms, such as a lip or mouth sore that doesn't heal, a white or reddish patch on the inside of the mouth, loose teeth, a growth or lump inside the mouth, mouth and ear pain, and difficult or painful swallowing. It can be caused due to excessive alcohol and tobacco consumption, extreme sun exposure of lips, human papillomavirus (HPV), and a weakened immune system. It can be treated through surgery or radiation therapy when detected at an early stage. It can also be cured via targeted therapy, which uses drugs or other substances to identify and attack cancer cells precisely. As oral cancer treatment can prevent the spread of oral cancer, its demand is rising across the globe.

Oral Cancer Treatment Market Trends:

At present, the increasing prevalence of oral cancer due to excessive consumption of cigarettes, cigars, pipes, chewing tobacco, and snuff represents one of the key factors supporting the growth of the market. Besides this, the rising awareness among the masses about the benefits of oral cancer treatments is offering lucrative growth opportunities to industry investors. Moreover, there is an increase in the demand for surgical therapies for the treatment of oral cancer across the globe. This, along with the thriving healthcare industry, is strengthening the growth of the market. In addition, governing agencies of several countries are extensively investing in healthcare infrastructure to improve the treatment of various diseases, which is propelling the growth of the market. Apart from this, the rising occurrence of human papillomavirus (HPV) infection, which is a sexually transmitted disease (STD) is catalyzing the demand for oral cancer treatment. Additionally, the growing number of hospitals and clinics providing efficient treatment of oral cancer, along with inflating income levels of individuals, is positively influencing the market. In line with this, the escalating demand for dental implants or grafts to repair the missing bones and tissues in the mouth during recovery is impelling the growth of the market. Furthermore, the growing consciousness among the masses about their oral health is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global oral cancer treatment market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on type, treatment type, age group, and end-user.

Type Insights:

• Oral Squamous Cell Carcinoma
• Oral Verrucous Carcinoma
• Mucoepidermoid Carcinoma
• Oral Cavity Lymphomas
   

The report has provided a detailed breakup and analysis of the oral cancer treatment market based on the type. This includes oral squamous cell carcinoma, oral verrucous carcinoma, mucoepidermoid carcinoma, and oral cavity lymphomas. According to the report, oral squamous cell carcinoma represented the largest segment.

Treatment Type Insights:

• Chemotherapy
• Radiation Therapy
• Targeted Therapy
• Surgery
• Others
   

A detailed breakup and analysis of the oral cancer treatment market based on the treatment type has also been provided in the report. This includes chemotherapy, radiation therapy, targeted therapy, surgery, and others. According to the report, radiation therapy accounted for the largest market share.

Age Group Insights:

• 30-49
• 50-69
• Above 70
   

A detailed breakup and analysis of the oral cancer treatment market based on the age group has also been provided in the report. This includes 30-49, 50-69, and above 70. According to the report, 50-69 accounted for the largest market share.

End-User Insights:

• Hospital
• Home Care
• Specialty Clinics
• Others
   

A detailed breakup and analysis of the oral cancer treatment market based on the end-user has also been provided in the report. This includes hospital, home care, specialty clinics, and others. According to the report, hospital accounted for the largest market share.

Regional Insights:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for oral cancer treatment. Some of the factors driving the North America oral cancer treatment market included the growing demand for surgical therapies, rising prevalence of oral cancer, increasing health care investments, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global oral cancer treatment market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Bristol-Myers Squibb Company, Merck & Co. Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Report Coverage:

Key Questions Answered in This Report:

• How has the global oral cancer treatment market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global oral cancer treatment market?
• What is the impact of each driver, restraint, and opportunity on the global oral cancer treatment market?
• What are the key regional markets?
• Which countries represent the most attractive oral cancer treatment market?
• What is the breakup of the market based on the type?
• Which is the most attractive type in the oral cancer treatment market?
• What is the breakup of the market based on the treatment type?
• Which is the most attractive treatment type in the oral cancer treatment market?
• What is the breakup of the market based on age group?
• Which is the most attractive age group in the oral cancer treatment market?
• What is the breakup of the market based on end-user?
• Which is the most attractive end-user in the oral cancer treatment market?
• What is the competitive structure of the global oral cancer treatment market?
• Who are the key players/companies in the global oral cancer treatment market?

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the oral cancer treatment market from 2017-2028.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global oral cancer treatment market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the oral cancer treatment industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.